Green background with newspaper pattern
Media Coverage

Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight

February 15, 2023
The Wall Street Journal
This article focuses on weight loss companies that use social media to promote a diabetes drug as a viable method for losing weight. Dr. Elizabeth Wassenaar is quoted in the piece, sharing her reaction to these advertisements and how they contribute to and drive an increase in eating disorders.

Read the Full Article from The Wall Street Journal

In an Instagram ad for online weight-loss service NextMed, a young woman holds the skin on her stomach and complains about her “little tummy pouch.” In an ad for a similar service—launched by Instacart’s former chief executive—a model wears a yellow bikini and weighs 102 pounds, according to a modeling-agency profile.

Digital health startups are racing to cash in on booming demand for diabetes drugs that are effective for weight loss, but some of the companies are advertising and prescribing the drugs to people who aren’t overweight.


Read More

Eating Recovery Center is accredited through the Joint Commission. This organization seeks to enhance the lives of the persons served in healthcare settings through a consultative accreditation process emphasizing quality, value and optimal outcomes of services.

Organizations that earn the Gold Seal of Approval™ have met or exceeded The Joint Commission’s rigorous performance standards to obtain this distinctive and internationally recognized accreditation. Learn more about this accreditation here.

Joint Commission Seal